Biological variation of ischaemia-modified albumin in healthy subjects

AIM: Ischaemia-modified albumin (IMA), as measured by the albumin-cobalt binding (ACB) test®, has been cleared by the US Food and Drug administration as a biomarker to exclude the presence of myocardial ischaemia in patients. Although there are a number of published studies detailing the clinical ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Govender, R, De Greef, J, Delport, R, Vermaak, WJH, Becker, PJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2008
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650841/
https://www.ncbi.nlm.nih.gov/pubmed/18568173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650841/
https://www.ncbi.nlm.nih.gov/pubmed/18568173

Ejemplares similares